News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
.jpg?sfvrsn=c0e17b74_2 "Pills (4.3)")
Study polypharmacology earlier in drug discovery, say researchers
Polypharmacology – the ability of a drug to affect more than one protein – should be studied early in the drug discovery pathway, and constantly monitored as the chemical structure is optimised in the design of the clinical candidate, leading researchers believe.
Scientists make ‘long-range weather forecasts’ of bowel cancer’s drug resistance
Scientists can use genetic ‘weather forecasting’ to predict how long it will take for bowel cancer to evolve resistance to a drug before a patient has even started treatment, a new study has shown.
-content.tmb-hbmobile.jpg?Culture=en&sfvrsn=fec93f9d_2 "Dispensing medicines for a clinical trial (Jan Chlebik for the ICR, 2014) content")
From breakthroughs to patient benefits: inside the ICR’s Clinical Trials and Statistics Unit
In this feature, Molly Andrews takes a close look at how the ICR’s Clinical Trials and Statistics Unit is turning scientific advances into benefits for patients, through cutting-edge clinical trials.
ICR among country’s top universities in first Knowledge Exchange Framework
The Institute of Cancer Research, London, has ranked highly in the UK’s first Knowledge Exchange Framework (KEF), a new Government assessment of universities’ partnerships and their influence on wider society.
Prince of Wales visits the Breast Cancer Now Toby Robins Research Centre at ICR
Today, His Royal Highness The Prince of Wales visited the Breast Cancer Now Toby Robins Research Centre, at The Institute of Cancer Research, London, 21 years after he officially opened it as the UK’s first dedicated breast cancer research centre in 1999.
Leading breast cancer researcher elected as Fellow of the Academy of Medical Sciences
Professor Nicholas Turner has been recognised with a prestigious Fellowship of the Academy of Medical Sciences for his excellence in breast cancer research and outstanding contribution to the field.
New type of treatment could reawaken immune response against prostate cancer
Targeting a molecule on the surface of immune cells could offer an exciting new way to treat prostate cancer by reawakening the immune response against it.
ICR announces appointment of new Chief Executive
Professor Kristian Helin, a world-leading cancer researcher with exceptional leadership experience in three different countries, will become Chief Executive of The Institute of Cancer Research, London, in September.
Ovarian cancer drug offers new genetically targeted approach against range of cancers
A type of drug used against ovarian and breast cancers could offer a brand new targeted approach for treating a range of cancers with particular genetic defects, including a common form of kidney cancer.
First Covid jab provides protection for most myeloma blood cancer patients
A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus.
Cancer researchers work through night as pandemic restricts access to labs
The number of scientists able to access labs dropped by almost 30 per cent when the latest coronavirus lockdown was announced, according to new data released by the ICR. Some 28% are therefore resorting to working in unsociable hours to keep their research going. The ICR is calling for financial support to avert a two-year delay in cancer research advances reaching patients.
ICR alumni inspire the next generation at the 2021 Student Conference
At this year’s virtual event, our current PhD students had the opportunity to meet with ICR alumni and ask them about their careers.
